SSRI antidepressants, such as sertraline, are the most commonly prescribed forms of antidepressants in the UK. Public concern, both about how effective antidepressants are and what side-effects occur whilst taking them, have led to much controversy over these drugs. Researchers publishing in The Lancet Psychiatry have completed a UK-based placebo-controlled trial in primary care patients which found no evidence that sertraline reduced depressive symptoms within 6 weeks, but that there were significant improvements in anxiety and quality of life.
Journalists came to the Science Media Centre to hear the authors discusses issues such as:
Dr Gemma Lewis, Senior Research Associate in Psychiatric Epidemiology, University College London (UCL)
Prof Glyn Lewis, Professor of Epidemiological Psychiatry, University College London (UCL)
A Roundup of comments accompanied this briefing.